With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

Columnist Caroline Gainer, who's had her own problems when seasons change this time of year, offers tips for those like her ...

The risk for moderate or severe COPD exacerbation was lower among those treated with SGLT-2is and with GLP-1 RAs versus DPP-4is.

Medically reviewed by Daniel More, MD Medications that target inflammation, such as immunotherapy and steroids, treat ...

SGLT2 inhibitors and GLP-1RAs yielded lower risks for COPD exacerbation than DPP-4 inhibitors among patients with type 2 diabetes.

chronic obstructive pulmonary disease (COPD), and patients who have received a lung transplant. It ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...

The episode, which doctors described as an “isolated crisis of bronchial spasm” began as a coughing fit in which Francis inhaled vomit. The longer respiratory crisis Francis suffered on Feb ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions. In ...

Many inhalers that are vital for patients with asthma or COPD are associated with societal harms that can worsen the very diseases the products are designed to treat. How can this dilemma be resolved?